A recent cost-utility analysis has found rTMS is not only more cost-effective than Electroconvulsive Therapy, it produces better health outcomes.
Medical Practitioners, Researchers and Mental Health Professionals in Melbourne are invited to join a Q&A session in August with Dr Martijn Arns, leading researcher in the areas of TMS in Depression, OCD and Neurofeedback in ADHD and Sleep Disorders.
Accumulating research suggests that if we first help patients with their sleep, this can go a long way in overcoming symptoms of ADHD.
Dr Sanil Rege, Consultant Psychiatrist and Founder of Psychscene and Psychscenehub speaks to Dr. Martijn Arns, Chief Scientific Adviser, neuroCare Group; Founding Director & Senior Researcher at Research Institute Brainclinics.
In classrooms the idea still prevails that easily distracted children and children with ADHD should not be seated too close to the window since they might be distracted by what is happening outside. ADHD is also often associated with difficulties in executive functioning and attention. Are these symptoms truly the core issue of ADHD? Or could there be a different underlying cause? In this article we will explain how some easily distracted children might be better off sitting closer to the window.
New study shows brain activity measured by QEEG can help predict which children may or may not respond to medications for ADHD
Researchers compare methods of treating ADHD in children and find that Neurofeedback, a medication free technique, has long-lasting effects, according to a recent study published in the medical journal European Child & Adolescent Psychiatry.
Researchers find cost of rTMS treatment to be more cost-effective as compared to antidepressant medication trials, factoring in financial commitment and quality of life post treatment.
Sleep expert and Professor of Neuroscience, Matthew Walker, breaks down the effects of sleep deprivations on the brain and body.
New study shows that magnetic brain stimulation (TMS) combined with concurrent psychotherapy is more effective than either technique alone with 66% of research subjects with Depression responding well in an average of 21 session. 65% of the group achieved long-term benefit.
We integrate leading research, digital therapeutics, physical devices, clinics, and professional education to offer the most comprehensive mental health solutions to patients, therapists and the research community.
Visit our global website
www.neurocaregroup.com
neuroCademy Professional Training & Science
www.neurocademy.com
